Willie Yu

Novel CRISPR-Cas9 BAP1 knockout pre-clinical tumor model recapitulates human melanoma tumorigenesis and immune evolution.

Author Correction: The repertoire of mutational signatures in human cancer

Author Correction: Pan-cancer analysis of whole genomes.

Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers

Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers.

The repertoire of mutational signatures in human cancer

The repertoire of mutational signatures in human cancer.

Pan-cancer analysis of whole genomes.

Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types.

Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia

Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy

Genomic profiling reveals mutational landscape in parathyroid carcinomas

Regulatory crosstalk between lineage-survival oncogenes <i>KLF5, GATA4</i> and <i>GATA6</i> cooperatively promotes gastric cancer development

Whole-Exome Sequencing Studies of Parathyroid Carcinomas Reveal Novel<i>PRUNE2</i>Mutations, Distinctive Mutational Spectra Related to APOBEC-Catalyzed DNA Mutagenesis and Mutational Enrichment in Kinases Associated With Cell Migration and Invasion

Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers

Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool

Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes

Exome sequencing of liver fluke–associated cholangiocarcinoma